LINDSAY MANJARRES: Open Payments
NPI 1154794816 · NORTH LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 9 payments from 7 companies in 2025. Trend: 2023 $792 · 2024 $578 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $148 |
| Boston Scientific Corporation | 1 | $133 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| ABBVIE INC. | 1 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $18 |
| SPR Therapeutics, Inc | 1 | $16 |
Products named: INTELLIS ADAPTIVESTIM, Intracept, RELISTOR, QULIPTA, Belbuca, NURTEC ODT, SPRINT PNS System, INCEPTIV.
Industry payments across NV — which companies pay providers there.
